Novo Nordisk is a Danish healthcare company focused on pharmaceutical treatments. It operates within the wider industry that supplies medical treatments to patients.
It is associated particularly with diabetes and obesity care, alongside other therapeutic areas. Research, medicine production and distribution support its global healthcare activities.
Pharmaceutical businesses turn scientific research into medicines used in healthcare. Clinical evidence, regulatory approvals and manufacturing quality are central to this process, while treatment needs, product access and patent protection influence the commercial life of medicines.
Relacionado con Noticias e información del mercado